Collaboration On Foreign Inspections Helps FDA Improve Resource Allocations
This article was originally published in The Tan Sheet
Executive Summary
FDA better allocated resources for foreign inspections based on information European and Australian authorities shared in a two-year pilot program, including conducting good manufacturing practices inspections that met the needs of multiple agencies.
You may also be interested in...
CHPA Product Quality & Operations Workshop In Brief
Facilitating switch is CHPA’s top priority
FDA Envisions International Focus Groups Navigating Globalization Issues
FDA could help create several international coalitions to carry out the agency’s globalization plan, which could allow for issue-specific groups focused on individual pharmaceutical sectors.
Private Third-Party Audits Could Enhance FDA’s Manufacturing Risk Analysis
Private and third-party audits could direct FDA to problematic facilities while easing some inspection burden on firms that already comply, but not replace FDA’s typical inspection duties.